(APLS) Apellis Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Apellis Pharmaceuticals | (APLS) share price targets
Complete technical analysis of Apellis Pharmaceuticals (APLS) by charts plus indicators, forecast predictions and share price targets for Apellis Pharmaceuticals (APLS)
Apellis Pharmaceuticals trades in USA in Health Care sector.
Showing technical analysis as on 2025-03-20 View latest technical analysis
10 day averaged volume of Apellis Pharmaceuticals is 1422206
Date | Daily Closing Price | Open | High | Low | Volume |
20 Thu Mar 2025 | 24.15 | 24.78 | 25.13 | 24.13 | 1.876 times |
19 Wed Mar 2025 | 24.81 | 24.70 | 25.58 | 24.17 | 1.343 times |
18 Tue Mar 2025 | 24.41 | 24.83 | 25.03 | 24.12 | 1.162 times |
17 Mon Mar 2025 | 25.11 | 24.70 | 25.34 | 24.43 | 0.703 times |
14 Fri Mar 2025 | 24.66 | 24.63 | 24.81 | 24.12 | 0.984 times |
13 Thu Mar 2025 | 24.37 | 25.03 | 25.28 | 24.27 | 1.063 times |
12 Wed Mar 2025 | 25.18 | 25.70 | 25.91 | 25.15 | 0.901 times |
11 Tue Mar 2025 | 25.52 | 25.14 | 25.75 | 24.78 | 0.984 times |
10 Mon Mar 2025 | 25.14 | 25.05 | 25.44 | 24.49 | 0.956 times |
07 Fri Mar 2025 | 25.04 | 25.00 | 25.49 | 24.43 | 1.069 times |
My analysis of stock is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if stock stays below 24.4, but if it comes above 24.4, then a intra day buy could be more profitable.
If you take a sell trade below 24.4, then use 24.4 as stoploss and 23.3 as target. However if you take a buy trade in stock , then use 24.4 as stoploss and 25.41 as target.
Share price targets for Apellis Pharmaceuticals (APLS)
Target Type | Value |
Downside Target | 23.77 |
Upside Target | 25.58 |
Upside Target | 27.35 |
Upside Target | 27.45 |
Upside Target | 28.14 |
Upside Target | 28.98 |
Upside Target | 30.60 |
Upside Target | 31.43 |
Upside Target | 33.05 |
Upside Target | 35.57 |
Upside Target | 35.72 |
Intraday share price targets for Apellis Pharmaceuticals (APLS)
Target Type | Value |
Downside Intraday Target | 23.65 |
Downside Intraday Target | 23.16 |
Upside Intraday Target | 25.11 |
Upside Intraday Target | 26.08 |
Upside Intraday Target | 24.62 |
Weekly technical analysis of Apellis Pharmaceuticals (APLS)
Date | Weekly Closing Price | Open | High | Low | Volume |
20 Thu Mar 2025 | 24.15 | 24.70 | 25.58 | 24.12 | 1.04 times |
14 Fri Mar 2025 | 24.66 | 25.05 | 25.91 | 24.12 | 0.955 times |
07 Fri Mar 2025 | 25.04 | 24.80 | 26.15 | 23.77 | 0.689 times |
28 Fri Feb 2025 | 25.15 | 27.51 | 28.14 | 24.33 | 1.978 times |
21 Fri Feb 2025 | 27.52 | 27.55 | 28.98 | 27.45 | 0.735 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Apellis Pharmaceuticals (APLS)
Date | Monthly Closing Price | Open | High | Low | Volume |
20 Thu Mar 2025 | 24.15 | 24.80 | 26.15 | 23.77 | 0.704 times |
28 Fri Feb 2025 | 25.15 | 28.36 | 30.60 | 24.33 | 0.731 times |
31 Fri Jan 2025 | 29.01 | 32.32 | 35.57 | 27.35 | 1.276 times |
31 Tue Dec 2024 | 31.91 | 33.80 | 35.72 | 31.43 | 0.359 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Apellis Pharmaceuticals (APLS)
Price action analysis of Apellis Pharmaceuticals ( (APLS) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Apellis Pharmaceuticals ( (APLS) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Apellis Pharmaceuticals ( (APLS) ) based on a short to mid term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Apellis Pharmaceuticals ( (APLS) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Apellis Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is gaining momentum.
MACD generated a BUY signal for Apellis Pharmaceuticals in short term but the buy signal is initial and weak.
Apellis Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Apellis Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Apellis Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 24.76 and Apellis Pharmaceuticals (APLS) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Apellis Pharmaceuticals (APLS) stock. Volume based technical analysis of Apellis Pharmaceuticals (APLS) stock is negative.
Apellis Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Apellis Pharmaceuticals ( (APLS) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Apellis Pharmaceuticals ( (APLS) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Apellis Pharmaceuticals ( (APLS) ) based on a short to mid term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Apellis Pharmaceuticals ( (APLS) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Apellis Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is gaining momentum.
MACD generated a BUY signal for Apellis Pharmaceuticals in short term but the buy signal is initial and weak.
Apellis Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Apellis Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Apellis Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 24.76 and Apellis Pharmaceuticals (APLS) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Apellis Pharmaceuticals (APLS) stock. Volume based technical analysis of Apellis Pharmaceuticals (APLS) stock is negative.
Apellis Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.